Cardiovascular Systems completes enrollment in Eclipse clinical trial
Cardiovascular Systems (NASDAQ: CSII)+ this week announced it completed enrollment in its Eclipse coronary trial. The company […]
Cardiovascular Systems (NASDAQ: CSII)+ this week announced it completed enrollment in its Eclipse coronary trial. The company […]
Endotronix announced today that it completed enrollment for a trial evaluating its Cordella pulmonary artery (PA) […]
Vaxxas today announced clinical trial data demonstrating the potential of its high-density microarray patch (HD-MAP) […]
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led […]
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B […]
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is […]
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralized clinical trial with a […]
Stratus Medical has announced the first patient enrolled in the COBRA study, a double-blinded, randomized […]
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of […]
Premia Spine has announced the publication of two-year outcomes from the TOPS facet joint replacement […]
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns […]
hbbAmong Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet […]
A randomized, triple-blinded clinical trial involving 35 women has found that active transcranial direct current […]
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that […]
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of […]
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes […]
One challenge of developing a drug for a disease with no approved therapies is that […]
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes […]
A double-blinded randomized controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) […]
OstomyCure announced today that it completed patient recruitment in the pivotal clinical trial of its […]
Medtronic (NYSE:MDT) today announced that it enrolled the first patient in a head-to-head trial of aortic […]
Inari Medical (Nasdaq:NARI) today announced that it enrolled the first patient in its Defiance trial for […]
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results […]
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts […]
Combination therapies are a mainstay of cancer care, the idea being that treatments that work […]
Real-world data startup Crescendo Health launched Thursday with $3.4 million from Define Ventures and other […]
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy […]
Abbott has announced the US Food and Drug Administration (FDA) approval of the company’s Eterna […]
Empirical Spine has revealed that it has recently completed the final step in the US […]
Congress passed the FDA Modernization Act 2.0 last week removing the requirement to use animal […]
Frontotemporal dementia (FTD) or frontotemporal lobar degeneration (FTLD) is a rare, rapidly progressing neurodegenerative disease […]
Dive Brief: The investment arms of billionaires Jeff Bezos and Bill Gates joined a $75 […]
Corvia Medical announced that it randomized the first patient in its Responder-HF global confirmatory trial of […]
Tech-enabled contract research organization Vial announced last week it raised $67 million in Series B […]
Posterior cervical foraminotomy is non-inferior to anterior cervical discectomy with fusion for patients with cervical […]
Dive Brief: Organizations including the operator of the largest particle physics laboratory in the world […]
Viz.ai has announced a strategic partnership with full-service, vascular clinical research organization (CRO) Vastrax. Together, […]
TriSalus Life Sciences today announced positive clinical results for its Pressure-Enabled Regional Immuno-Oncology technology. The […]
Premia Spine recently announced the publication of one-year outcomes from the TOPS facet replacement system’s […]
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.